Findings

What do systematic reviews say?

5 questions · 5 findings · 4 reviews · Heart

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 20%Low 2 · 40%Moderate 1 · 20%High 1 · 20%

Myocardial infarction · patients with coronary heart disease

Antibiotics showed no clear difference in myocardial infarction at maximum compared with placebo or no intervention (high certainty).

1 finding from 1 review

Antibiotics for secondary prevention of coronary heart disease 2021 · Cochrane Headline outcomes only
RR 0.95 [0.88, 1.03]
17 studies · 25523 participants
High

Myocardial infarction at maximum · patients without heart failure

The intervention probably leads to lower myocardial infarction at maximum (moderate certainty).

1 finding from 1 review

Beta‐blockers in patients without heart failure after myocardial infarction 2021 · Cochrane Headline outcomes only
RR 0.76 [0.67, 0.86]
19 studies · 19606 participants
Moderate

Myocardial infarction · patients with suspected or diagnosed myocardial infarction

Beta‐blockers showed no clear difference in myocardial infarction at maximum compared with placebo or no intervention (low certainty).

1 finding from 1 review

Beta‐blockers for suspected or diagnosed acute myocardial infarction 2019 · Cochrane Headline outcomes only
RR 0.89 [0.75, 1.08]
14 studies · 6825 participants
Low

Myocardial infarction · patients with acute coronary syndrome

It is very uncertain whether drug‐eluting stents changes myocardial infarction at maximum compared with bare‐metal stents (very low certainty).

1 finding from 1 review

Drug‐eluting stents versus bare‐metal stents for acute coronary syndrome 2017 · Cochrane Headline outcomes only
RR 0.98 [0.82, 1.18]
18 studies · 10217 participants
Very low

Major cardiovascular events (cardiovascular mortality or non‐fatal myocardial infarction) at maximum · patients without heart failure

The intervention may leads to lower major cardiovascular events (cardiovascular mortality or non‐fatal… (low certainty).

1 finding from 1 review

Beta‐blockers in patients without heart failure after myocardial infarction 2021 · Cochrane Headline outcomes only
RR 0.72 [0.62, 0.83]
15 studies · 14994 participants
Low